Crossmark

Empowering exhausted T cells of Glioblastoma patients by Neurotransmitters and Neuropeptides: decreasing immune checkpoint inhibitors, and increasing CD3zeta, proliferation and Glioblastoma arrest

Crossref DOI link: https://doi.org/10.1007/s00262-025-04226-6

Published Online: 2026-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Levite, Mia

Ilouz, Nili

Galun, Eithan

Shoshan, Yigal
License Information

Text and Data Mining valid from 2026-01-27

Version of Record valid from 2026-01-27
More Information

Article History

Received: 11 August 2025

Accepted: 31 October 2025

First Online: 27 January 2026

Declarations

:

: The authors declare no conflict of interest.

: The study on T cells of Glioblastoma patients complies with the ethical guidelines and has an IRB approval No. 0482–21-HMO from Hadassah Hebrew University Medical Center, Jerusalem 91120, Israel.

: All the Glioblastoma patients signed informed consents.

Document is current

Any future updates will be listed below